Skip to main content

Table 2 Patient and tumor characteristics

From: Immune cell profile of sentinel lymph nodes in patients with malignant melanoma – FOXP3+ cell density in cases with positive sentinel node status is associated with unfavorable clinical outcome

Patient group

All patients

SLN-negative

SLN-positive

Age – median (range)

54 (27–79)

54 (27–79)

54 (27–76)

Sex

   

 Male

27

16

11

 Female

33

19

14

Tumor thickness (mm)

   

 1.01–2.0

29

21

8

 2.01–4.0

20

8

12

 >4.0

11

6

5

Tumor site

   

 Extremities

31

18

13

 Trunk

29

17

12

Histologic type

   

 SSM

37

24

13

 NM

19

10

9

 ALM

4

1

3

Ulceration

   

 Absent

37

26

11

 Present

20

9

11

 Unknown

3

-

3

Progression in 5 years

   

 No

38

28

10

 Yes

22

7

15

 5-year survival (%)

43/60 (72)

31/35 (89)

12/25 (48)

  1. SSM, superficial spreading melanoma; NM, nodular melanoma; ALM, acral lentiginous melanoma.